ERNA vs GEN · P/E 0.0, rev $582.0K vs P/E 17, rev $5.00B
Eterna Therapeutics Inc (ERNA) versus Gen Digital Inc. (GEN) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Not investment advice. Open the ERNA and GEN stock pages for the full models.
Not investment advice.